R Foti

Author PubWeight™ 21.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int 2001 1.60
2 Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. Cell Death Differ 2008 1.20
3 Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant 1997 1.05
4 Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 2010 0.96
5 Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo. Immunology 1998 0.94
6 The PML nuclear bodies-associated protein TTRAP regulates ribosome biogenesis in nucleolar cavities upon proteasome inhibition. Cell Death Differ 2011 0.91
7 Interleukin-10 is a mesangial cell growth factor in vitro and in vivo. Lab Invest 1997 0.90
8 De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis. J Am Soc Nephrol 1996 0.87
9 Cardiac hydatid cyst with clinical features resembling subaortic stenosis. Am Heart J 1989 0.86
10 Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease. J Nucl Cardiol 1999 0.85
11 Usefulness of exercise tomographic myocardial perfusion imaging for detection of restenosis after coronary stent implantation. Am J Cardiol 2000 0.84
12 Reduced axial bone mineral content in patients taking an oral anticoagulant. South Med J 1990 0.83
13 CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol 1997 0.83
14 Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. Reumatismo 2013 0.80
15 Assessment of the biological activity of synthetic salmon calcitonin by intranasal administration in healthy volunteers. Drugs Exp Clin Res 1991 0.79
16 Deoxyspergualin inhibits mesangial cell proliferation and major histocompatibility complex class II expression. J Am Soc Nephrol 1995 0.79
17 Comparison of the Recent-Onset Arthritis Disability questionnaire with the Health Assessment Questionnaire disability index in patients with rheumatoid arthritis. Clin Exp Rheumatol 2011 0.78
18 [Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment]. Reumatismo 2007 0.78
19 Acute effects of salmon calcitonin in man include stimulation of the renin-angiotensin-aldosterone system. Miner Electrolyte Metab 1987 0.77
20 Effects of ovariectomy and 17 beta-estradiol on bone GLA protein in growing rats: an indirect evidence for estrogen receptors in bone cells. Exp Clin Endocrinol 1988 0.77
21 The effects of muscle-building exercise on forearm bone mineral content and osteoblast activity in drug-free and anabolic steroids self-administering young men. Bone Miner 1991 0.77
22 Differences in the time course of the effects of oophorectomy in women on parameters of bone metabolism and interleukin-1 levels in the circulation. Bone Miner 1993 0.77
23 Usefulness of platelet glycoprotein IIb/IIIa inhibitors in coronary stenting for reconstruction of complex lesions: procedural and 30 day outcome. Cardiologia 1999 0.76
24 Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease. Clin Exp Immunol 2000 0.76
25 Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction. J Nucl Cardiol 1998 0.75
26 Caroli's disease: a case report. Ital J Gastroenterol Hepatol 1997 0.75
27 [Computerization of cardiologic departments]. Cardiologia 1995 0.75
28 Diagnostic value of exercise electrocardiography for predicting a positive scintigraphic test in patients with complete right bundle branch block. Cardiologia 1999 0.75
29 [Early myocardial involvement in collagen diseases. An endomyocardial biopsy study]. Minerva Cardioangiol 1991 0.75
30 Long-term angiographic follow-up after successful repeat balloon angioplasty for in-stent restenosis. Clin Cardiol 2001 0.75
31 [The immediate and midterm results of percutaneous mitral valvuloplasty in subjects over 60]. Cardiologia 1996 0.75
32 Bone mineral content of the hyperprolactinemic rat femur by single photon absorptiometry. Horm Metab Res 1988 0.75
33 [Perfusion myocardial scintigraphy after coronary angiography: a way to choose from medical, surgical, or intervention therapy]. Cardiologia 1999 0.75
34 Accuracy of exercise testing in the assessment of the severity of myocardial ischemia as determined by means of technetium-99m tetrofosmin SPECT scintigraphy. J Nucl Cardiol 2000 0.75
35 Metabolic-dependent increase of serum beta 2-microglobulin levels in patients with Paget's disease of bone. Horm Metab Res 1992 0.75
36 [Modification of cortical and trabecular mineral density of the femur, induced by ipriflavone therapy, Clinical results after 12 months]. Clin Ter 1995 0.75
37 Endomyocardial biopsy in diagnosis and management of cardiovascular manifestations of systemic lupus erythematosus (SLE). Clin Rheumatol 1989 0.75
38 [Significance of electrocardiographic projection of ST-segment depression during exercise test in the prediction of the location of regional myocardial ischemia]. Cardiologia 1998 0.75
39 Serum antibodies to human enteric coronavirus-like particles in Australia, South Africa, Indonesia, Niue, and Papua New Guinea. Acta Virol 1990 0.75
40 Evaluation of the biological activity of unmodified synthetic eel calcitonin rectal capsules. Comparison with intramuscular administration and placebo. Int J Clin Pharmacol Res 1992 0.75
41 Calcium-induced serum bone Gla protein variations in preterm newborns. J Endocrinol Invest 1987 0.75
42 Postoophorectomy bone loss is associated with reduced bone Gla protein serum levels: a possible effect of osteoblastic insufficiency. Calcif Tissue Int 1987 0.75
43 Slow-release nifedipine associated with muzolimine in the treatment of mild to moderate essential hypertension. Am J Nephrol 1986 0.75